Coronaviruses, one of a variety ofviruses that cause colds, have been making people cough and sneeze seeminglyforever. But occasionally, a new version infects people and causes seriousillness and deaths.
That is happening now with the coronavirus that has killed at least 26 people and sickened at least 900 since it emerged in central China in December. The World Health Organization is monitoring the viruss spread to see whether it will turn into a global public health emergency (SN: 1/23/20).
Among the ill are two people in theUnited States who contracted the virus during travels in China. A Chicago womanin her 60s is the second U.S. case of the new coronavirus, the Centers forDisease Control and Prevention confirmed January 24 in a news conference.
Officials are currently monitoring 63people across 22 states for signs of the pneumonia-like disease, includingfever, cough and other respiratory symptoms. Of those people, 11 have testednegative for the virus. Two, including the newest case and anotherpatient in Seattle, tested positive, the CDC reported (SN: 1/21/20).
Headlines and summaries of the latest Science News articles, delivered to your inbox
France reported two cases on January 24as well, the first in Europe.
Much still remains unknown about the new coronavirus (SN: 1/10/20), which for now is being called 2019 novel coronavirus, or 2019-nCoV. Lessons learned from previous coronavirus outbreaks, including severe acute respiratory syndrome, or SARS, and Middle East respiratory syndrome, or MERS, may help health officials head off some of the more serious consequences from this virus outbreak.
Coronaviruses are round and surroundedby a halo of spiky proteins, giving them a resemblance to a crown or the sunswispy corona.
Four major categories, or genera, ofcoronavirus exist. Theyre known by the Greek letters alpha, beta, delta andgamma. Only alpha and beta coronaviruses are known to infect people. Theseviruses spread through the air, and just four types (known as 229E, NL63, OC43and HKU1) are responsible for about 10 to 30 percent of colds around the world.
What makes a virus a coronavirus is onlyloosely enshrined in its DNA. The coronavirus designation is less about thegenetics and more about the way it appears under a microscope, says Brent C.Satterfield, cofounder and chief scientific officer of Co-Diagnostics, acompany based in Salt Lake City and Gujarat, India, that is developingmolecular tests for diagnosing coronavirus infections.
Coronaviruses genetic makeup iscomposed of RNA, a single-stranded chemical cousin of DNA. Viruses in thefamily often arent very similar on the genetic level, with some types havingmore differences between them than humans have from elephants, Satterfieldsays.
The new viruss proteins are between 70and 99 percent identical to their counterparts in the SARS virus, says KarlaSatchell, a microbiologist and immunologist at Northwestern University FeinbergSchool of Medicine in Chicago.
Usually coronavirus illnesses are fairly mild, affecting just the upper airway. But the new virus, as well as both SARS and MERS, are different.
Those three types of betacoronavirusescan latch onto proteins studding the outside of lung cells, and penetrate muchdeeper into the airway than cold-causing coronaviruses, says Anthony Fauci,director of the U.S. National Institute of Allergy and Infectious Diseases inBethesda, M.D. The 2019 version is a disease that causes more lung diseasethan sniffles, Fauci says.
Damage to the lungs can make the virusesdeadly. In 2003 and 2004, SARS killed nearly 10 percent of the 8,096 people in29 countries who fell ill. A total of 774 people died, according to the WorldHealth Organization.
MERS is even more deadly, claiming about30 percent of people it infects. Unlike SARS, outbreaks of that virus are stillsimmering, Fauci says. Since 2012, MERS has caused 2,494 confirmed cases in 27countries and killed 858 people.
MERS can spread from person to person,and some superspreaders have passed the virus on to many others. Mostfamously, 186 people contracted MERS after one businessman unwittingly broughtthe virus to South Korea in 2015 and spread it to others. Another superspreaderwho caught MERS from that man passedthe virus to 82 people over just two days while being treated in a hospitalemergency room (SN: 7/8/16).
Right now, 2019-nCoV appears to be less virulent, with about a 4 percent mortality rate. But that number is still a moving target as more cases are diagnosed, Fauci says. As of January 23, the new coronavirus had infected more than 581 people, with about a quarter of those becoming seriously ill, according to the WHO. By January 24, the number of reported infections had risen to at least 900.
An analysis of the illness in the first41 patients diagnosed with 2019-nCoV from Wuhan, China suggests that the virusacts similarly to SARS and MERS. Like the other two, 2019-nCoV causespneumonia. But unlike those viruses, the new one rarelyproduces runny noses or intestinal symptoms, researchers report January 24in the Lancet. Most of the peopleaffected in that first group were healthy, with fewer than a third havingchronic medical conditions that could make them more vulnerable to infection.
Coronaviruses are zoonotic, meaning theyoriginate in animals and sometimes leap to humans. The first 2019-nCoV infectionsdetected in December were in patients who had visited the Huanan seafood marketin Wuhan. The market was closed January 1, but health officials have yet todetermine from which type of animal the virus jumped to humans.
Bats are often thought of as a source ofcoronaviruses, but in most cases they dont pass the virus directly on tohumans. SARS probably first jumped from bats into raccoon dogs or palm civetsbefore making the leap to humans. All the pieces necessary to re-create SARSare circulatingamong bats, though that virus has not been seen since 2004 (SN: 11/30/17).
MERS, meanwhile, wentfrom bats to camels before leaping to humans (SN: 2/25/14). A paper published January 22 in the Journal of Medical Virology suggeststhat the new coronavirus has components from bat coronaviruses, but that snakes may havepassed the virus to humans. But many virologists areskeptical that snakes are behind the outbreak (SN: 1/24/20).
It depends on the coronavirus, butneither SARS or MERS have been able to sustain human-to-human transmission theway influenza viruses can, Fauci says. Thats because the viruses havent fullyadapted to infect humans, and maybe they never will, he says.
Still, this is a family of viruses thatwas formerly just the common cold, he says. But now, in the last 18 years,weve had three examples of it jumping species and causing serious disease inhumans. He and colleagues wrote an article publishedJanuary 23 in JAMA to illustrate whatthey see as the growing threat from coronaviruses.
In Wuhan, the new coronavirus has beenable to transmit down a chain of up to four people, health officials said. Fivemembers of a family from Shenzhen, China caught the virus when they visitedinfected relatives in Wuhan, researchers report January 24 in the Lancet. Travelers have also carried thevirus from China to at least seven other countries, including the UnitedStates. No human-to-human transmission has yet been reported outside of China,the WHO said. All of the deaths have also been in that country.
Epidemiologists are franticallycalculating how infectious the new virus is, says Maimuna Majumder, acomputational epidemiologist at Boston Childrens Hospital and Harvard MedicalSchool.
The number that describes how manypeople a newly infected person is likely to pass a virus to is called R0,pronounced Rnaught (SN: 5/28/19). SARS, forinstance, had an R0 between two and five, meaning that in a fullysusceptible population an infected person could potentially spread the virus totwo to five others. (Highly contagious measles, in comparison, has a R0from 12 to 18.)
Estimates for the infectivity of the newvirus range from the WHOs estimate of 1.4 to 2.5 to a much bigger 3.6 to 4.0calculation from Jonathan Read of Lancaster University in England andcolleagues. Reads group estimates that only about5.1 percent of cases in Wuhan have been identified. The researchersreported the preliminary results January 24 at medRxiv.org.
Thats probably not because the Chinesegovernment is covering up how bad the outbreak is, Majumder says. Many peoplemay have had only mild symptoms or none at all. Those people probably wouldntgo to the doctor and get tested for the virus.
Majumder and Harvard colleague KennethMandl used a different method to calculate R0 for the new virus,estimating based on cases reported as of January 22 that its transmissibilityfalls from2.0 to 3.3. Their results were posted to SSRN on January 23.
Meanwhile, Christian Althaus and JulienRiou, both of the University of Bern in Switzerland, posted data to Githubsupporting their calculation that the new viruss infectivity is between 1.4 and 3.8. Each of thosecalculations was arrived at using different methods. While they are slightlydifferent, they overlap, and Majumder says shes reassured that the numbers aresimilar.
Similar infectivity to SARS doesnt meanthe new virus will spread like that one did.
Having SARS in [our] history can helpinform some these decisions that were going to make now. Back then, we wereless prepared than we are now, Majumder says.
For now, all doctors can do is treatsymptoms of the new disease. Researchers have also developed some experimentaltreatments based on SARS and MERS, including antibodies that may help combatthe infections, Fauci says.
Getting samples of the new virus mayallow researchers to develop monoclonal antibodies in the lab. Or scientistsmay be able to take immune B cells from people who already have recovered fromthe virus to produce antibodies to help other infected people.
Some antiviral medications have shown promise in treating MERS, and are being tested for their effectiveness against 2019-nCoV. Experimental vaccines, Facui wrote in JAMA, including some based on RNA, are also in the works.
Erin Garcia de Jesus contributed to reporting of this story.
See the original post:
How the new coronavirus stacks up against SARS and MERS - Science News
- F.D.A. Says Millions Got Unapproved Drugs, Should the new bioequivalence and bioanalytical guidelines for 2010, be made more stringent [Last Updated On: April 15th, 2010] [Originally Added On: April 15th, 2010]
- F.D.A. Says Millions Got Unapproved Drugs, Should the new bioequivalence and bioanalytical guidelines for 2010, be made more stringent [Last Updated On: April 15th, 2010] [Originally Added On: April 15th, 2010]
- GSK, MedTrust launch iPhone/iPad app for cancer trials [Last Updated On: June 11th, 2010] [Originally Added On: June 11th, 2010]
- GSK, MedTrust launch iPhone/iPad app for cancer trials [Last Updated On: June 11th, 2010] [Originally Added On: June 11th, 2010]
- 22 Million Australian Cloud computing initiative to benefit life science researchers [Last Updated On: June 19th, 2010] [Originally Added On: June 19th, 2010]
- GE Healthcare announces SaaS Electronic Medical Records Management [Last Updated On: June 19th, 2010] [Originally Added On: June 19th, 2010]
- 22 Million Australian Cloud computing initiative to benefit life science researchers [Last Updated On: June 19th, 2010] [Originally Added On: June 19th, 2010]
- GE Healthcare announces SaaS Electronic Medical Records Management [Last Updated On: June 19th, 2010] [Originally Added On: June 19th, 2010]
- How useful would be the Single-patient clinical trials for improving the hopes of Personalized medicine [Last Updated On: August 12th, 2010] [Originally Added On: August 12th, 2010]
- How useful would be the Single-patient clinical trials for improving the hopes of Personalized medicine [Last Updated On: August 12th, 2010] [Originally Added On: August 12th, 2010]
- Life Sciences at Oracle Open World 2010 [Last Updated On: October 11th, 2010] [Originally Added On: October 11th, 2010]
- ChIP Enrichment Analysis can speed up drug discovery [Last Updated On: October 11th, 2010] [Originally Added On: October 11th, 2010]
- GE’s healthymagination initiative lead Smart Patient Room to improve patient safety goes live at Bassett Medical Center [Last Updated On: October 11th, 2010] [Originally Added On: October 11th, 2010]
- The SaaS impact on solution selling for ISVs (via Inner Lining) [Last Updated On: October 11th, 2010] [Originally Added On: October 11th, 2010]
- Oracle starts the Oracle Health Sciences Institute (OHSI), in partnership with Sun Labs [Last Updated On: October 11th, 2010] [Originally Added On: October 11th, 2010]
- 70% of Pharmaceutical organisations outsource at least one PV activity. This level is expected to increase to 80% by 2012 [Last Updated On: October 26th, 2010] [Originally Added On: October 26th, 2010]
- Insurance coverage for healthcare IT software, to protect healthcare IT companies from damages inflicted by their software [Last Updated On: November 7th, 2010] [Originally Added On: November 7th, 2010]
- India announce Heart Surgery for $1000 USD [Last Updated On: November 7th, 2010] [Originally Added On: November 7th, 2010]
- Indian Healthcare IT market & Oracle’s presence in Indian Healthcare [Last Updated On: November 7th, 2010] [Originally Added On: November 7th, 2010]
- Insurance coverage for healthcare IT software, to protect healthcare IT companies from damages inflicted by their software [Last Updated On: November 7th, 2010] [Originally Added On: November 7th, 2010]
- India announce Heart Surgery for $1000 USD [Last Updated On: November 7th, 2010] [Originally Added On: November 7th, 2010]
- Indian Healthcare IT market & Oracle’s presence in Indian Healthcare [Last Updated On: November 7th, 2010] [Originally Added On: November 7th, 2010]
- Harvard Medical Schools new automated safety surveillance system provides faster early warnings in the postmarket evaluation of medical device safety [Last Updated On: November 29th, 2010] [Originally Added On: November 29th, 2010]
- SalesForce.com partner introduces CRM for clinical trial management on Force Platform [Last Updated On: November 29th, 2010] [Originally Added On: November 29th, 2010]
- Widespread fraud in the Clinical Trial of Drugs is pervasive event in United States [Last Updated On: November 29th, 2010] [Originally Added On: November 29th, 2010]
- Scott Stern Kellogg School of Management speaks about “New Drug Development: From Laboratory to Blockbuster to Generic,” [Last Updated On: November 29th, 2010] [Originally Added On: November 29th, 2010]
- MNC Pharma tries to capture the $1.9 billion Indian OTC market by selling Drugs through India’s 170000 post offices [Last Updated On: November 29th, 2010] [Originally Added On: November 29th, 2010]
- collaborative clinical trials management software for Central Laboratories [Last Updated On: November 29th, 2010] [Originally Added On: November 29th, 2010]
- Clinical Trial and Pharmacovigilance process automation [Last Updated On: November 29th, 2010] [Originally Added On: November 29th, 2010]
- Microsoft in Clinical Trials Management System (CTMS) and Electronic Data Capture (EDC) [Last Updated On: November 29th, 2010] [Originally Added On: November 29th, 2010]
- Oracle Business Intelligence Enteprise Edition (OBIEE) for Clinical Trial Management System (CTMS) [Last Updated On: November 29th, 2010] [Originally Added On: November 29th, 2010]
- trends in the life sciences and pharma research and development outsourcing (RDO) [Last Updated On: November 29th, 2010] [Originally Added On: November 29th, 2010]
- Sanofi-Aventis ties up with Oxford Univ for oncology research in India [Last Updated On: December 20th, 2010] [Originally Added On: December 20th, 2010]
- PharmaNet unveils touch screen capable data capture platform for Phase I Clinical Trials [Last Updated On: December 20th, 2010] [Originally Added On: December 20th, 2010]
- Adverse Events in Hospitals- United States Department of Health Report slams current measures in US hospitals [Last Updated On: December 21st, 2010] [Originally Added On: December 21st, 2010]
- IBM Files Application to Patent The Patent [Last Updated On: January 4th, 2011] [Originally Added On: January 4th, 2011]
- How to improve R&D productivity: the pharmaceutical industry’s grand challenge [Last Updated On: February 14th, 2011] [Originally Added On: February 14th, 2011]
- AstraZeneca Announce Real-World Evidence Data Collaboration [Last Updated On: February 14th, 2011] [Originally Added On: February 14th, 2011]
- How to improve R&D productivity: the pharmaceutical industry’s grand challenge [Last Updated On: February 14th, 2011] [Originally Added On: February 14th, 2011]
- AstraZeneca Announce Real-World Evidence Data Collaboration [Last Updated On: February 14th, 2011] [Originally Added On: February 14th, 2011]
- Medication adherence improves, When Patients Share Their Stories [Last Updated On: March 13th, 2011] [Originally Added On: March 13th, 2011]
- Questions for the CRO [Last Updated On: March 13th, 2011] [Originally Added On: March 13th, 2011]
- Clinical Research Sites Struggle With Increasing Trial Complexity yet most depend on, Google (or other search sites) as the primary information tool [Last Updated On: March 13th, 2011] [Originally Added On: March 13th, 2011]
- Medication adherence improves, When Patients Share Their Stories [Last Updated On: March 13th, 2011] [Originally Added On: March 13th, 2011]
- Questions for the CRO [Last Updated On: March 13th, 2011] [Originally Added On: March 13th, 2011]
- Clinical Research Sites Struggle With Increasing Trial Complexity yet most depend on, Google (or other search sites) as the primary information tool [Last Updated On: March 13th, 2011] [Originally Added On: March 13th, 2011]
- Law of the land can help or destroy the Pharmacovigilance system [Last Updated On: March 27th, 2011] [Originally Added On: March 27th, 2011]
- Law of the land can help or destroy the Pharmacovigilance system [Last Updated On: March 27th, 2011] [Originally Added On: March 27th, 2011]
- Coast To Coast AM - 15.11.2011 - 1/4 - Regenerative Medicine/Dulce Base - Video [Last Updated On: November 29th, 2011] [Originally Added On: November 29th, 2011]
- Coast To Coast AM - 15.11.2011 - 4/4 - Regenerative Medicine/Dulce Base - Video [Last Updated On: November 29th, 2011] [Originally Added On: November 29th, 2011]
- HIV Resistant Genes...Rhesus Negative, Excess PK [Last Updated On: November 30th, 2011] [Originally Added On: November 30th, 2011]
- Indian Government’s new dose of strong medicine to bring cheers to Foreign Pharma CEOs who cut their teeth by struggling to convince Indian pharma to change sales practices [Last Updated On: December 18th, 2011] [Originally Added On: December 18th, 2011]
- Indian Government’s new dose of strong medicine to bring cheers to Foreign Pharma CEOs who cut their teeth by struggling to convince Indian pharma to change sales practices [Last Updated On: December 18th, 2011] [Originally Added On: December 18th, 2011]
- Drug Reps Soften Their Sales Pitches, as pharma learns from Disney [Last Updated On: January 15th, 2012] [Originally Added On: January 15th, 2012]
- Drug Reps Soften Their Sales Pitches, as pharma learns from Disney [Last Updated On: January 15th, 2012] [Originally Added On: January 15th, 2012]
- Oracle Unveils Oracle® Health Sciences Omics Data Bank as Part of Oracle Health Sciences Translational Research Center [Last Updated On: January 29th, 2012] [Originally Added On: January 29th, 2012]
- Oracle Unveils Oracle® Health Sciences Omics Data Bank as Part of Oracle Health Sciences Translational Research Center [Last Updated On: January 29th, 2012] [Originally Added On: January 29th, 2012]
- One Way to Teach Your Boss About Social Media [Last Updated On: February 12th, 2012] [Originally Added On: February 12th, 2012]
- “The Banks Can Do It, Why Can’t Hospitals?” [Last Updated On: February 12th, 2012] [Originally Added On: February 12th, 2012]
- Internet on any Display Device, or internet on TV at low cost can it transform Healthcare or Clinical Research [Last Updated On: February 12th, 2012] [Originally Added On: February 12th, 2012]
- Is Life Sciences the New Frontier for Analytics? [Last Updated On: February 12th, 2012] [Originally Added On: February 12th, 2012]
- Internet on any Display Device, or internet on TV at low cost can it transform Healthcare or Clinical Research [Last Updated On: February 12th, 2012] [Originally Added On: February 12th, 2012]
- Is Life Sciences the New Frontier for Analytics? [Last Updated On: February 12th, 2012] [Originally Added On: February 12th, 2012]
- Regenerative Medicine: Current Concepts and Changing Trends - Video [Last Updated On: February 12th, 2012] [Originally Added On: February 12th, 2012]
- bluebird bio Appoints David Davidson, M.D., as Chief Medical Officer [Last Updated On: February 16th, 2012] [Originally Added On: February 16th, 2012]
- privacy controlled social networking to connect patients with caregivers [Last Updated On: February 19th, 2012] [Originally Added On: February 19th, 2012]
- SOCIAL CRM and its Impact on Pharmaceutical Industry [Last Updated On: February 19th, 2012] [Originally Added On: February 19th, 2012]
- SOCIAL CRM and its Impact on Pharmaceutical Industry [Last Updated On: February 19th, 2012] [Originally Added On: February 19th, 2012]
- privacy controlled social networking to connect patients with caregivers [Last Updated On: February 19th, 2012] [Originally Added On: February 19th, 2012]
- British Government launches Government Cloud Store with 257 Cloud Computing Suppliers [Last Updated On: February 26th, 2012] [Originally Added On: February 26th, 2012]
- Patient Adherence Investments by Pharma Companies Current Scenario [Last Updated On: February 26th, 2012] [Originally Added On: February 26th, 2012]
- Pharma looks to mobile strategies to effectively reach prescribers | mHIMSS [Last Updated On: February 26th, 2012] [Originally Added On: February 26th, 2012]
- British Government launches Government Cloud Store with 257 Cloud Computing Suppliers [Last Updated On: February 26th, 2012] [Originally Added On: February 26th, 2012]
- Pharma looks to mobile strategies to effectively reach prescribers | mHIMSS [Last Updated On: February 26th, 2012] [Originally Added On: February 26th, 2012]
- Patient Adherence Investments by Pharma Companies Current Scenario [Last Updated On: February 26th, 2012] [Originally Added On: February 26th, 2012]
- Predictive Analytics for Patient Adherence [Last Updated On: March 4th, 2012] [Originally Added On: March 4th, 2012]
- Predictive Analytics for Patient Adherence [Last Updated On: March 4th, 2012] [Originally Added On: March 4th, 2012]
- Genetic manipulation boosts growth of brain cells linked to learning, enhances effects of antidepressants [Last Updated On: March 10th, 2012] [Originally Added On: March 10th, 2012]
- Can “Clinical Data Integration on the Cloud” be a reality? [Last Updated On: March 11th, 2012] [Originally Added On: March 11th, 2012]
- Can “Clinical Data Integration on the Cloud” be a reality? [Last Updated On: March 11th, 2012] [Originally Added On: March 11th, 2012]